Tristel plc (AIM:TSTL)

Market Cap	165.49M
Revenue (ttm)	41.93M
Net Income (ttm)	6.49M
Shares Out	47.69M
EPS (ttm)	0.14
PE Ratio	25.63
Forward PE	21.95
Dividend	0.14 (3.84%)
Ex-Dividend Date	Nov 28, 2024

Volume	64,870
Average Volume	61,753
Open	346.20
Previous Close	352.50
Day's Range	344.00 - 355.00
52-Week Range	341.25 - 510.00
Beta	0.14
RSI	36.50
Earnings Date	Feb 24, 2025

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 233
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2024, Tristel's revenue was 41.93 million, an increase of 16.45% compared to the previous year's 36.01 million. Earnings were 6.49 million, an increase of 45.46%.